Article Details

Eagle Pharmaceuticals Inc (EGRX) Receives $69.40 Consensus Price Target from Analysts

Retrieved on: 2019-06-07 09:51:06

Tags for this article:

Click the tags to see associated articles and topics

Eagle Pharmaceuticals Inc (EGRX) Receives $69.40 Consensus Price Target from Analysts. View article details on hiswai:

Excerpt

<div><b>WINTON GROUP</b> Ltd bought a new stake in shares of Eagle Pharmaceuticals in the 4th quarter valued at approximately $9,552,000. Legal & General ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo